cDNA array reveals differential gene expression following chronic neuroleptic administration: implications of synapsin II in haloperidol treatment
Open Access
- 19 September 2002
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 82 (6) , 1533-1539
- https://doi.org/10.1046/j.1471-4159.2002.01104.x
Abstract
The cDNA expression array is a recently developed scientific tool that can profile the differential expression of several hundreds of genes simultaneously and is therefore advantageous in the study o...Keywords
This publication has 46 references indexed in Scilit:
- Chronic treatment with certain antipsychotic drugs preserves upregulation of regulator of G-protein signalling 2 mRNA in rat striatum as opposed to c-fos mRNANeuroscience Letters, 2001
- Functional Magnetic Resonance Imaging Evidence for Disrupted Basal Ganglia Function in SchizophreniaAmerican Journal of Psychiatry, 2001
- Altered expression of a-type but not b-type synapsin isoform in the brain of patients at high risk for Alzheimer's disease assessed by DNA microarray techniqueNeuroscience Letters, 2001
- Stoichiometry of Tyrosine Hydroxylase Phosphorylation in the Nigrostriatal and Mesolimbic Systems In VivoJournal of Neurochemistry, 2000
- CREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular SignalsAnnual Review of Biochemistry, 1999
- Clozapine, haloperidol, and the D 4 antagonist PNU-101387G: in vivo effects on mesocortical, mesolimbic, and nigrostriatal dopamine and serotonin releaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1998
- The Human Synapsin II Gene PromoterPublished by Elsevier ,1995
- A Clinical Guide to Antipsychotic DrugsDrugs, 1992
- Decreased striatal release of acetylcholine following withdrawal from long-term treatment with haloperidol: Modulation by cholinergic, dopamine-D1 and -D2 mechanismsNeuropharmacology, 1990
- Dopamine receptors and the dopamine hypothesis of schizophreniaSynapse, 1987